Infectious agents and cancer · 2026
HIV, HPV, and oral health in Tanzania: a scoping review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gedion Kalipa, Blackwood Elizabeth R, Mwobobia Judith, Semali Innocent, Moshi Mainen Julius, Owibingire Sira, Mwaiswelo Richard O, Mashalla Yohana, Ferrari Guido, Bartlett John, Osazuwa-Peters Nosayaba
Аннотация
BACKGROUND: People living with HIV (PLHIV) are at an increased risk of oral manifestations, including those linked to human papillomavirus (HPV). In Tanzania, the prevalence and impact of oral HPV among PLHIV remain unknown. This scoping review aimed to map evidence and identify gaps at the intersection of HIV, HPV, and oral health.
METHODS: We conducted a scoping review of studies on oral health in relation to HIV or HPV. Studies involving HPV or oral health among PLHIV were included, while studies conducted outside Tanzania, lacked empirical data, or did not report relevant outcomes were excluded. Outcomes were prevalence of oral manifestations, HPV detection, HPV vaccination, and intervention effectiveness.
RESULTS: Forty-four studies were included. One assessed HPV and oral health; none evaluated HPV vaccination effects on oral outcomes. Prevalence of oral manifestations among PLHIV increased from 10% to 34% over two decades. Antiretroviral therapy reduced oropharyngeal candidiasis but showed no effect on head and neck cancers.
CONCLUSIONS: Evidence on HPV-related oral lesions among PLHIV in Tanzania is scarce. Research is needed to define prevalence, risk factors, and barriers to care, which will inform policies to expand HPV vaccination, strengthen the oral workforce, and integrate oral health into HIV services.
METHODS: We conducted a scoping review of studies on oral health in relation to HIV or HPV. Studies involving HPV or oral health among PLHIV were included, while studies conducted outside Tanzania, lacked empirical data, or did not report relevant outcomes were excluded. Outcomes were prevalence of oral manifestations, HPV detection, HPV vaccination, and intervention effectiveness.
RESULTS: Forty-four studies were included. One assessed HPV and oral health; none evaluated HPV vaccination effects on oral outcomes. Prevalence of oral manifestations among PLHIV increased from 10% to 34% over two decades. Antiretroviral therapy reduced oropharyngeal candidiasis but showed no effect on head and neck cancers.
CONCLUSIONS: Evidence on HPV-related oral lesions among PLHIV in Tanzania is scarce. Research is needed to define prevalence, risk factors, and barriers to care, which will inform policies to expand HPV vaccination, strengthen the oral workforce, and integrate oral health into HIV services.